High-intensity exercise training in mice with cardiomyocyte-specific disruption of Serca2

Journal of Applied Physiology

Volumn 108, Issue 5, 2010, Pages 1311-1320

  Ericsson, Madelene ^a   Andersson, Kristin B ^b,c   Amundsen, Brage H ^a,d   Torp, Sverre H ^d,e   Sjaastad, Ivar ^b,c   Christensen, Geir ^b,c   Sejersted, Ole M ^b,c   Ellingsen, Øyvind ^a,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Calcium transport; Cardiomyopathy; Conditional knockout; Heart failure; Maximal oxygen; Sarco(endo)plasmic reticulum ATPase type 2; Uptake

Indexed keywords

ATP2A2 PROTEIN, MOUSE; MESSENGER RNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADAPTATION; ANIMAL; ARTICLE; CALCIUM SIGNALING; ECHOGRAPHY; ENZYMOLOGY; EXERCISE; EXERCISE TOLERANCE; GENETICS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE; METABOLISM; MOUSE; MOUSE MUTANT; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; TIME;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCIUM SIGNALING; EXERCISE TOLERANCE; HEART VENTRICLES; HYPERTROPHY, RIGHT VENTRICULAR; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OXYGEN CONSUMPTION; PHYSICAL EXERTION; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 77951947604     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01133.2009     Document Type: Article

References (38)

1. Aldridge GM, Podrebarac DM, Greenough WT, Weiler I.J. The use of total protein stains as loading controls: an. alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172: 250-254, 2008.
2. Andersson KB, Birkeland JA, Finsen AV, Louch WE, Sjaastad I, Wang Y, Chen J, Molkentin JD, Chien KR, Sejersted OM, Christensen G. Moderate heart dysfunction in mice with inducible cardiomyocyte-speciflc excision of the Serca2 gene. J Mol Cell Cardiol 47 180-187, 2009.
3. Andersson KB, Finsen AV, Sjåland C, Winer LH, Sjaastad 1, Ødegaard A, Louch WE, Wang Y, Chen J, Chien KR, Sejersted OM, Christensen G. Mice carrying a conditional Serca2flox allele for the generation of Ca2+ handling-deficient mouse models. Cell Caldum 46: 219-225, 2009.
4. Andersson KB, Winer LH, Mørk HK, Molkentin J, Jaisser F. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts. Transgenic Res 2009 Nov 6. [Epub ahead of print.]
5. Astrand PO, Rodahl K, Dahl HA, Strømme SB. Textbook of Work Physiology: Physiological Bases of Exercise. Champaign, IL: Human Kinetics, 2003.
6. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Norwell, MA: Kluwer Academic Publishers, 2001, p. 452.
7. Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, Possemiers N, Wuyts FL, Vrints CJ. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 25: 1797 - 1805, 2004.
8. Finsen AV, Christensen G, Sjaastad I. Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J Appl Physiol 98: 680-689, 2005. (Pubitemid 40129982)
9. Hearse DJ, Stewart DA, Braimbridge MV. Hypothermic arrest and potassium, arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res 36: 481-489, 1975.
10. 2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil 15: 145-148, 2008.
11. Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, Condorelli G, Ellingsen O. Activation or inactivation of cardiac Akt/ mTOR signaling diverges physiological from, pathological hypertrophy. J Cell Physiol 214: 316-321, 2008. (Pubitemid 350308987)
12. 2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban. J Mol Cell Cardiol 43: 354-361, 2007.
13. Kemi OJ, Haram PM, Wisloff U, Ellingsen O. Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation 109: 2897-2904, 2004. (Pubitemid 38780305)
14. Kemi OJ, Loennechen JP, Wisloff U, Ellingsen O. Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy. J Appl Physiol 93: 1301-1309, 2002.
15. Lakatta EG, Vinogradova TM, Maltsev VA. The missing link in the mystery of normal automaticity of cardiac pacemaker cells. Ann NY Acad Sci 1123: 41-57, 2008.
16. Lehnart SE, Schillinger W, Pieske B, Prestle J, Just H, Hasenfuss G. Sarcoplasmic reticulum proteins in. heart failure. Ann NY Acad Sci 853: 220-230, 1998. (Pubitemid 28515044)
17. Loennechen JP, Beisvag V, Arbo I, Waldum HL, Sandvik AK, Knardahl S, Ellingsen O. Chronic carbon monoxide exposure in vivo induces myocardial endothelin-1 expression and hypertrophy in rat. Pharmacol Toxicol 85: 192-197, 1999. (Pubitemid 29484986)
18. Loennechen JP, Nilsen OG, Arbo I, Aadahl P, Nilsen T, Waldum HL, Sandvik AK, Ellingsen O. Chronic exposure to carbon, monoxide and nicotine: endomelin ET(A) receptor antagonism attenuates carbon, monoxide-induced myocardial hypertrophy in rat. Toxicol Appl Pharmacol 178: 8-14, 2002. (Pubitemid 34084725)
19. Louch WE, Hougen K, Mork HK, Swift F, Aronsen JM, Sjaastad I, Reims HM, Roald B, Andersson KB, Christensen G, Sejersted OM. Sodium, accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. J Physiol 588: 465-478, 2010.
20. Maltsev VA, Lakatta EG. Normal heart rhythm is initiated and regulated by an intracellular calcium clock within, pacemaker cells. Heart Lung Circ 16: 335-348, 2007.
21. Maria Sarullo F, Gristina T, Brusca I, Milla S, Raimondi R, Sajeva M, Maria La Chiusa S, Serio G, Paterna S, Di Pasquale P, Castello A. Effect of physical training on exercise capacity, gas exchange and N- terminal pro-brain natriuretic peptide levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 13: 812-817, 2006. (Pubitemid 44454856)
22. Mercather JJ, Lompre AM, Due P, Boheler KR, Fraysse JB, Wisnewsky C, Allen PD, Komajda M, Schwartz K. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85: 305-309, 1990. (Pubitemid 20030324)
23. Merritt DM, Sealy WC, Young WG Jr, Harris FS. Potassium, magnesium, and neostigmine for controlled cardioplegia; evaluation with the isolated perfused cat heart. AMA Arch Surg 76: 365-371, 1958.
24. 2+ transients in mice during early congestive heart failure. J Mol Cell Cardiol 43: 177-186, 2007.
25. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801, 2002. (Pubitemid 34987553)
26. Pate RR, Kriska A. Physiological basis of the sex difference in cardiorespiratory endurance. Sports Med 1: 87-98, 1984. (Pubitemid 14088554)
27. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45: 1007-1013, 2007. (Pubitemid 46631569)
28. Shephard RJ, Åstrand PO. Endurance in Sport. Oxford, UK: Blackwell Science, 2000.
29. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
30. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endomelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1.14: 464-469, 1991.
31. Taylor CR, Maloiy GM, Weibel ER, Langman VA, Kamau JM, Seeherman HJ, Heglund NC. Design of the mammalian respiratory system. III. Scaling maximum aerobic capacity to body mass: wild and domestic mammals. Respir Physiol 44: 25-37, 1981. (Pubitemid 11111493)
32. 2+ exchanger in normal and detubulated rat cardiomyocytes. j Mol Cell Cardiol 35: 1325-1337, 2003.
33. Wagner PD. A theoretical analysis of factors determining VO2 MAX at sea level and altitude. Respir Physiol 106: 329-343, 1996.
34. 2max and cardiac hypertrophy. Am J Physiol Heart Circ Physiol 280: H1301-H1310, 2001.
35. Wisloff U, Loennechen JP, Currie S, Smith GL, Ellingsen O. Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, Ca2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc Res 54: 162-174, 2002. (Pubitemid 34327946)
36. Wisloff U, Loennechen JP, Falck G, Beisvag V, Currie S, Smith G, Ellingsen O. Increased contractility and calcium, sensitivity in cardiac myocytes isolated from endurance trained rats. Cardiovasc Res 50: 495-508, 2001. (Pubitemid 32480243)
37. Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q, Fernstrom M, Rezaei K, Lee SJ, Koch LG, Britton SL. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307: 418-420, 2005. (Pubitemid 40139985)
38. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115: 3086-3094, 2007. (Pubitemid 46956498)